Clinical Trials Sponsored by Galena Biopharma, Inc.

Total 383 results

Shanghai Zhimeng Biopharma, Inc.
Tigermed Consulting Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

Hepatitis B, Chronic

China
Cytosite Biopharma Inc.
University of Alabama at Birmingham

Completed

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Healthy Volunteers

United States
Renmin Hospital of Wuhan University
Ansun Biopharma, Inc.

Completed

DAS181 for Severe COVID-19: Compassionate Use

COVID-19

China
Ansun Biopharma, Inc.
National Institutes of Health (NIH)

Completed

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

Influenza

United States
Green Cross Corporation
Quintiles, Inc.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Healthy Male

United States
Memorial Sloan Kettering Cancer Center
Ambrilia Biopharma, Inc.

Completed

Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.

Prostate Cancer

United States
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Not yet recruiting

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

Bacterial Infections
ProCertus BioPharm, Inc
University of Wisconsin, Madison

Terminated

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Radiodermatitis

United States
Pharmosa Biopharm Inc.
Novotech (New Zealand) Limited

Not yet recruiting

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

Pulmonary Arterial Hypertension

New Zealand
Pharmosa Biopharm Inc.
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Pulmonary Arterial Hypertension

Australia
Mycenax Biotech Inc.
TSH Biopharm Corporation Limited

Terminated

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Taiwan
Zenith Epigenetics
Astellas Pharma Inc; Newsoara Biopharma Co., Ltd.

Recruiting

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States, China
Weill Medical College of Cornell University
Oncolys BioPharma Inc

Completed

Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Bacterial Infections

Australia, United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

Bacterial Infections

Australia, United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

Bacterial Infections

Australia
Sorrento Therapeutics, Inc.
VetStem Biopharma, Inc.; Fresno Community Hospital and Medical Center

Completed

Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 (CoronaStem1)

Covid19

United States
Acrotech Biopharma Inc.
Clinipace Worldwide; Beckloff Associates, Inc.; Kansas City Bioanalytical Laboratories

Completed

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Multiple Myeloma

United States
Weill Medical College of Cornell University
Oncolys BioPharma Inc

Terminated

Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease

Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers (QPX9003)

Bacterial Infections

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

Bacterial Infections

United States
Green Cross Corporation
Dream CIS, Inc.

Completed

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

Hemophilia

Korea, Republic of
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

Australia, New Zealand, Spain
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Australia, New Zealand, Spain
University of Utah
Bristol-Myers Squibb; Acrotech Biopharma Inc.

Withdrawn

Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation (BENEFIT)

Metastatic Adenocarcinoma
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

Colorectal Cancer

Australia, New Zealand
Dance Biopharm Inc.
Profil Institut für Stoffwechselforschung GmbH

Completed

Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

Germany
Healeon Medical Inc
Terry, Glenn C., M.D.

Enrolling by invitation

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (ADcSVF-IBD)

Inflammatory Bowel Diseases

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.; ProPharma Group

Completed

CLBP Single-Arm Long-Term Follow-up Study

Chronic Low Back Pain

United States
Healeon Medical Inc
Terry, Glenn C., M.D.

Enrolling by invitation

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders (ADcSVF-COPD)

Lung Disease

United States, Honduras
University of Michigan Rogel Cancer Center
Pfizer; Acrotech Biopharma Inc.

Recruiting

Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Metastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian Carcinoma

United States
University of California, Los Angeles
Mylan Pharmaceuticals Inc; Theravance Biopharma

Recruiting

Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO)

COPD | Acute Respiratory Failure

United States
Dorothy Sipkins, MD, PhD
Acrotech Biopharma Inc.; Amgen

Withdrawn

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

B-cell Acute Lymphoblastic Leukemia

United States
Nutrition Institute, Slovenia
Valens Int. d.o.o., Slovenija

Completed

Influence of Beta-glucan Enriched Barley Flour in Bread on Glycemic Response

Glycemic Index
ReveraGen BioPharma, Inc.
University of Pittsburgh; Cooperative International Neuromuscular Research...

Completed

Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada, United Kingdom, Sweden, Australia, Israel
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

DAS181 Single Dose Escalation Study in Healthy Adults

Healthy

United States
Green Cross Corporation
C&R Research, Inc.; CRScube

Unknown

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Gastritis

Korea, Republic of
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Single Dose Escalating Study of DAS181 in Adults

Influenza

United States
University of Cologne
Pfizer; F2G Biotech GmbH; Basilea Pharmaceutica; Cidara Therapeutics Inc.; Matinas...

Recruiting

FungiScope - A Global Emerging Fungal Infection Registry (FungiScope)

Invasive Fungal Disease

Germany
Elena Pope
Avicanna Inc

Withdrawn

The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial

Pain | Epidermolysis Bullosa | Itch

Canada
Glenn J. Hanna
ImmunityBio, Inc.

Recruiting

PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer | Metastatic Head-and-neck Squamous-cell Carcinoma

United States
Matinas BioPharma Nanotechnologies, Inc.
University of Cologne; The Clinical Trials Centre Cologne

Withdrawn

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
Pfizer; Acrotech Biopharma Inc.

Recruiting

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

United States
ProCertus BioPharm, Inc
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

Alopecia | Radiodermatitis

United States
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC; Oncolys BioPharma Inc

Recruiting

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States
ProCertus BioPharm, Inc
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Radiodermatitis

United States
Glenn J. Hanna
Actuate Therapeutics Inc.

Active, not recruiting

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Adenoid Cystic Carcinoma | Metastatic Cancer | Salivary Gland Cancer | Recurrent Salivary Gland Cancer

United States
Glenn J. Hanna
Secura Bio, Inc.

Active, not recruiting

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Metastatic Head and Neck Cancer | Advanced Head and Neck Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Advanced Head and Neck Cancer

United States
Healeon Medical Inc
Terry, Glenn C., M.D.; Micheal Nissenbaum, MD

Enrolling by invitation

Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes (GARM-W)

Frail Elderly Syndrome | Aging | Degenerative Disease

United States
Toshihiko Doi
Merck Sharp & Dohme LLC; Oncolys BioPharma Inc

Completed

Special Combination of OBP-301 and Pembrolizumab

Advanced Solid Tumor

Japan

Clinical Trials Sponsored by Galena Biopharma, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations